Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.

Pharmacogenomics - 1 Feb 2009

Borgiani Paola, Ciccacci Cinzia, Forte Vittorio, Sirianni Elisabetta, Novelli Lucia, Bramanti Placido, Novelli Giuseppe

Abstract excerpt

INTRODUCTION: It is known that warfarin treatment is problematic, due to its narrow therapeutic range and to the great interindividual variability. Numerous papers have shown the important contribution of CYP2C9 and VKORC1 genetic variants to this variability. Recently, a new SNP within the CYP4F...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Atrial Fibrillation
Share to Cytochrome P450 Family 4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Valve Prosthesis Implantation

Share to Mixed Function Oxygenases

Share to Venous Thrombosis

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 19207028
DOI: 10.2217/14622416.10.2.261

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19207028-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.PMID 19207028Read ↗

Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.Semantic proximity Read ↗

Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis.Semantic proximity Read ↗

Impact of genetic factors (CYP2C9, VKORC1 and CYP4F2) on warfarin dose requirement in the Turkish population.Semantic proximity Read ↗

Warfarin anticoagulant therapy: a Southern Italy pharmacogenetics-based dosing model.Semantic proximity Read ↗

CYP4F2 genetic variant alters required warfarin dose.Semantic proximity Read ↗

Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population.Semantic proximity Read ↗

Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.Semantic proximity Read ↗

Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients.Semantic proximity Read ↗

Warfarin pharmacogenetics: a controlled dose-response study in healthy subjects.Semantic proximity Read ↗

Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.Semantic proximity Read ↗

Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry.Semantic proximity Read ↗

Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.